Bosutinib, Free Base
Bosutinib is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer. Originally synthesized by Wyeth, it is being developed by Pfizer.
Cancer Research and Antivirals
|Appearance||white to off white|
Send us your enquiry for Bosutinib, Free Base. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Bosutinib, Free Base email us and we will include your contribution on the website.